Dear Friends of ICRF,
I have been privileged to be associated with ICRF for over 20 years, as a grant reviewer, board member, member of the national organization, and both as a Chairman of the Board and President of the Los Angeles chapter. Recently, I have been reelected as an Interim Chair of the Board, and I am very grateful to work with our devoted board and advisory members.My personal involvement with ICRF stems from the fact that I am a cancer biologist working in this field for many years at UCLA. Like Israeli cancer scientists, I share similar experiences in both the hardship and the competitiveness to continue raising funds to support research and staff. For all of us, the passion of the research and teaching are to contribute to the advancement of new therapeutics and diagnostics of various cancers for the well-being of mankind.
The process of identifying the talents and innovations of Israeli scientists who compete and get support from ICRF is effective. The grants permit both young investigators and established scientists to initiate and extend significant research investigations. Also, there are funds for fellowships that directly help young scientists in their preparation of an academic career. I surely feel that the research undertaken by the funded ICRF scientists are of the highest quality. I feel confident in saying that they are on par with established and reputed scientists in North America, Europe, and the rest of the world. I am also very proud that two of the Israeli scientists that ICRF has supported have then won the Nobel Prize for Chemistry. (Dr. Hershko and Dr. Ciechanover)
It is reassuring that the ICRF mission has been very successful, and we should continue to support core funding of the leading Israeli scientists in cancer research. I wish to extend my sincere enthusiasm to my friends and colleagues for their continuous support.
Benjamin Bonavida, Ph.D.